141990-06-9

Basic information

• Product Name: 1,3,4,6-Tetra-O-acetyl-2-O-(2,3,4-tri-O-benzoyl-a-L-fucopyranosyl)-D-galactopyranose
• Synonyms: 1,3,4,6-Tetra-O-acetyl-2-O-(2,3,4-tri-O-benzoyl-a-L-fucopyranosyl)-D-galactopyranose;2-O-(2,3,4-Tri-O-benzoyl-6-deoxy-α-L-galactopyranosyl)-α-D-galactopyranose Tetraacetate
• CAS NO: 141990-06-9
• Molecular Formula: C41H42O17
• Molecular Weight: 0
• Product Categories: Oligosaccharides
• Mol File: 141990-06-9.mol

Chemical Properties

• Appearance: /
• Solubility: Chloroform, Dichloromethane, Ethyl Acetate
• CAS DataBase Reference: 1,3,4,6-Tetra-O-acetyl-2-O-(2,3,4-tri-O-benzoyl-a-L-fucopyranosyl)-D-galactopyranose(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3,4,6-Tetra-O-acetyl-2-O-(2,3,4-tri-O-benzoyl-a-L-fucopyranosyl)-D-galactopyranose(141990-06-9)
• EPA Substance Registry System: 1,3,4,6-Tetra-O-acetyl-2-O-(2,3,4-tri-O-benzoyl-a-L-fucopyranosyl)-D-galactopyranose(141990-06-9)

Safety Data

• Hazardous Substances Data: 141990-06-9(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
1,3,4,6-Tetra-O-acetyl-2-O-(2,3,4-tri-O-benzoyl-a-L-fucopyranosyl)-D-galactopyranose is used as a key intermediate in organic synthesis for the development of various complex molecules. Its unique structure allows for further functionalization and modification, making it a valuable compound in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 1,3,4,6-Tetra-O-acetyl-2-O-(2,3,4-tri-O-benzoyl-a-L-fucopyranosyl)-D-galactopyranose is used as a building block for the synthesis of novel drug candidates. Its structural diversity and reactivity enable the creation of new molecules with potential therapeutic applications.
Used in Research and Development:
1,3,4,6-Tetra-O-acetyl-2-O-(2,3,4-tri-O-benzoyl-a-L-fucopyranosyl)-D-galactopyranose is also utilized in research and development laboratories for studying the properties and reactivity of complex carbohydrates and their derivatives. 1,3,4,6-Tetra-O-acetyl-2-O-(2,3,4-tri-O-benzoyl-a-L-fucopyranosyl)-D-galactopyranose serves as a model for understanding the behavior of similar structures in biological systems and for developing new synthetic strategies.
Used in Material Science:
In the field of material science, 1,3,4,6-Tetra-O-acetyl-2-O-(2,3,4-tri-O-benzoyl-a-L-fucopyranosyl)-D-galactopyranose can be used as a component in the development of advanced materials with specific properties, such as improved biocompatibility or enhanced mechanical strength.
Overall, 1,3,4,6-Tetra-O-acetyl-2-O-(2,3,4-tri-O-benzoyl-a-L-fucopyranosyl)-D-galactopyranose is a versatile compound with a wide range of applications in various industries, including organic synthesis, pharmaceuticals, research and development, and material science. Its unique chemical structure and properties make it a valuable asset in the development of new molecules and materials with potential applications in various fields.

Upstream product

• 108-24-7 acetic anhydride 
• 160412-82-8 allyl 3,4,6-tri-O-acetyl-β-D-glucopyranoside 
• 161007-95-0 2,3,4-tri-O-benzoyl-α-L-rhamnopyranosyltrichloroacetimidate 
• 92418-39-8 1,3,4,6-tetra-O-acetyl-α,β-D-glucopyranose 
• 14218-08-7 2,3,4-tri-O-benzoyl-α-L-rhamnopyranosyl bromide 
• 19186-40-4 1,3,4,6-tetra-O-acetyl-α-D-galactopyranoside 

Downstream Products

• 573700-75-1 2,3,4-tri-O-benzoyl-α-L-rhamnopyranosyl-(1->2)-3,4,6-tri-O-acetyl-α-D-glucopyranosyl bromide 
• 19057-67-1 ophiopogonin C 

Relevant articles and documents

Total synthesis and structural revision of rebaudioside S, a steviol glycoside

The total synthesis of rebaudioside S, a minor steviol glycoside from the leaves of Stevia rebaudiana, was investigated via a modular strategy, culminating not only in the first and highly efficient synthesis of Reb-S and analogues thereof but also in the revision of the originally proposed structure. The modular strategy dictated the application of C2-branched disaccharide Yu donors to forge C-13 steviol glycosidic linkages, posing considerable challenges in stereoselectivity control. Through systematic investigations, the effect of the internal glycosidic linkage configuration on the glycosylation stereoselectivity of 1,2-linked disaccharide donors was disclosed, and the intensified solvent effect by the 4,6-O-benzylidene protecting group was also observed with glucosyl donors. Through the orchestrated application of these favorable effects, the stereoselectivity problems were exquisitely tackled.

The synthesis of gracillin and dioscin: Two typical representatives of spirostanol glycosides

Two representative spirostanol saponins that have the typical structure for the sugar moiety, diosgenyl α-L-rhamnopyranosyl-(1→2)-[β-D-glucopyranosyl-(1→3)]- β-D-glucopyranoside (gracillin) and diosgenyl α-L-rhamnopyranosyl-(1→2)-[α-L-rhamnopyranosyl-(1→4)]- β-D-glucopyranoside (dioscin), were easily synthesized by a general approach. A procedure using guanidine for the selective deblocking of acetyl while retaining benzoyl protecting groups is described.